3.33
price down icon1.19%   -0.04
after-market Dopo l'orario di chiusura: 3.33
loading
Precedente Chiudi:
$3.37
Aprire:
$3.42
Volume 24 ore:
274.92K
Relative Volume:
1.67
Capitalizzazione di mercato:
$58.73M
Reddito:
$52.55M
Utile/perdita netta:
$-23.69M
Rapporto P/E:
-3.5426
EPS:
-0.94
Flusso di cassa netto:
$-15.29M
1 W Prestazione:
+4.39%
1M Prestazione:
-22.92%
6M Prestazione:
+10.63%
1 anno Prestazione:
+83.98%
Intervallo 1D:
Value
$3.22
$4.10
Intervallo di 1 settimana:
Value
$2.77
$4.10
Portata 52W:
Value
$1.3003
$6.22

Exagen Inc Stock (XGN) Company Profile

Name
Nome
Exagen Inc
Name
Telefono
(760) 560-1501
Name
Indirizzo
1261 LIBERTY WAY, VISTA, CA
Name
Dipendente
179
Name
Cinguettio
@ExagenInc
Name
Prossima data di guadagno
2025-03-11
Name
Ultimi documenti SEC
Name
XGN's Discussions on Twitter

Confronta XGN con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Diagnostics & Research icon
XGN
Exagen Inc
3.33 58.73M 52.55M -23.69M -15.29M -0.94
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
512.65 193.40B 42.88B 6.34B 7.27B 16.53
Diagnostics & Research icon
DHR
Danaher Corp
204.96 146.49B 23.88B 3.90B 5.30B 5.28
Diagnostics & Research icon
A
Agilent Technologies Inc
119.85 34.19B 6.53B 1.26B 1.31B 4.35
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
412.40 33.54B 3.90B 887.87M 798.08M 10.67
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
185.42 32.69B 15.41B 1.37B 2.11B 7.50

Exagen Inc Stock (XGN) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2022-08-05 Downgrade KeyBanc Capital Markets Overweight → Sector Weight
2021-10-15 Ripresa Cowen Outperform
2021-04-15 Iniziato Canaccord Genuity Buy
2020-11-10 Iniziato KeyBanc Capital Markets Overweight
2020-10-08 Iniziato BTIG Research Buy
2020-06-02 Ripresa Cantor Fitzgerald Overweight
2019-10-14 Iniziato Cantor Fitzgerald Overweight
2019-10-14 Iniziato Cowen Outperform
2019-10-14 Iniziato William Blair Outperform
Mostra tutto

Exagen Inc Borsa (XGN) Ultime notizie

pulisher
Mar 12, 2025

Exagen Inc. Reports Record Revenue and Positive Outlook - TipRanks

Mar 12, 2025
pulisher
Mar 12, 2025

Exagen Inc. (NASDAQ:XGN) Q4 2024 Earnings Call Transcript - Insider Monkey

Mar 12, 2025
pulisher
Mar 12, 2025

Exagen Full Year 2024 Earnings: EPS Beats Expectations - Yahoo Finance

Mar 12, 2025
pulisher
Mar 12, 2025

Exagen’s Positive Outlook: Buy Rating Backed by Strong Performance and Growth Potential - TipRanks

Mar 12, 2025
pulisher
Mar 12, 2025

Exagen Inc (XGN) Q4 2024 Earnings Call Highlights: Record Revenue and Strategic Growth Initiatives - Yahoo Canada Finance

Mar 12, 2025
pulisher
Mar 12, 2025

Exagen Inc. Reports Record 2024 Financial Results - TipRanks

Mar 12, 2025
pulisher
Mar 11, 2025

BTIG maintains Buy rating, $5 target on Exagen stock By Investing.com - Investing.com South Africa

Mar 11, 2025
pulisher
Mar 11, 2025

Earnings call transcript: Exagen Inc Q4 2024 sees revenue growth and stock rise - Investing.com

Mar 11, 2025
pulisher
Mar 11, 2025

Exagen posts smaller-than-expected fourth-quarter net loss -March 11, 2025 at 09:39 am EDT - Marketscreener.com

Mar 11, 2025
pulisher
Mar 11, 2025

Exagen Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 11, 2025
pulisher
Mar 11, 2025

EXAGEN INC. SEC 10-K Report - TradingView

Mar 11, 2025
pulisher
Mar 11, 2025

Exagen Inc. (XGN) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Finance

Mar 11, 2025
pulisher
Mar 11, 2025

EXAGEN DIAGNOSTICS Earnings Results: $XGN Reports Quarterly Earnings - Nasdaq

Mar 11, 2025
pulisher
Mar 11, 2025

Exagen Inc. Reports Strong Fourth Quarter and Full-Year 2024 Results and Business Highlights - The Manila Times

Mar 11, 2025
pulisher
Mar 11, 2025

Exagen Inc. Reports Strong Fourth Quarter and Full-Year 2024 Results - TradingView

Mar 11, 2025
pulisher
Mar 09, 2025

EXAGEN DIAGNOSTICS Earnings Preview: Recent $XGN Insider Trading, Hedge Fund Activity, and More - Nasdaq

Mar 09, 2025
pulisher
Mar 09, 2025

Exagen (XGN) Expected to Announce Earnings on Tuesday - Defense World

Mar 09, 2025
pulisher
Mar 07, 2025

Exagen Inc. (NASDAQ:XGN) Short Interest Update - Defense World

Mar 07, 2025
pulisher
Mar 04, 2025

Is Exagen (NASDAQ:XGN) Using Debt In A Risky Way? - Simply Wall St

Mar 04, 2025
pulisher
Mar 02, 2025

Investors in Exagen (NASDAQ:XGN) have unfortunately lost 84% over the last five years - Yahoo Finance

Mar 02, 2025
pulisher
Feb 25, 2025

Exagen Inc. to Announce Fourth Quarter and Full-Year 2024 Financial Results on March 11, 2025 - GlobeNewswire

Feb 25, 2025
pulisher
Feb 25, 2025

When Will Exagen Report Q4 Earnings? Key Date for Autoimmune Testing Investors - StockTitan

Feb 25, 2025
pulisher
Feb 18, 2025

Stocks Surge Across Health Services and Industry Sectors: Nuvve, Exagen, and Flexsteel Lead the Way - HPBL

Feb 18, 2025
pulisher
Feb 17, 2025

What Do Wall Street Analysts Think About Exagen Inc (NASDAQ: XGN) Stock? - Stocks Register

Feb 17, 2025
pulisher
Feb 17, 2025

Exagen Inc. (NASDAQ:XGN) Short Interest Up 260.8% in January - MarketBeat

Feb 17, 2025
pulisher
Feb 14, 2025

Volcon, Flexsteel, Palantir and More See Stock Surge After Positive Earnings and Strategic Deals - HPBL

Feb 14, 2025

Exagen Inc Azioni (XGN) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$144.50
price up icon 3.20%
diagnostics_research DGX
$166.42
price down icon 1.03%
diagnostics_research LH
$236.83
price down icon 1.01%
diagnostics_research WAT
$373.13
price down icon 1.51%
diagnostics_research MTD
$1,216.02
price down icon 2.18%
diagnostics_research IQV
$185.42
price up icon 1.06%
Capitalizzazione:     |  Volume (24 ore):